Type I interferons as vaccine adjuvants against infectious diseases and cancer (Q37130475)

18 August 2017

1 reference

title

Type I interferons as vaccine adjuvants against infectious diseases and cancer (English)

1 reference

ORCID Public Data File 2021

18 August 2017

1 reference

Enrico Proietti

1 reference

author name string

Laura Bracci

series ordinal

1 reference

18 August 2017

Valentina La Sorsa

series ordinal

1 reference

18 August 2017

Filippo Belardelli

series ordinal

1 reference

18 August 2017

language of work or name

1 reference

1 April 2008

1 reference

Expert Review of Vaccines

18 August 2017

published in

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

18 August 2017

page(s)

373-381

1 reference

Advances in vaccine adjuvants

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Vaccine adjuvants revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Toll-like receptor control of the adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Interferon, a growing cytokine family: 50 years of interferon research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Injection of mice with antibody to interferon renders peritoneal macrophages permissive for vesicular stomatitis virus and encephalomyocarditis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Human interferons alpha, beta and omega

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Interferons alpha and beta as immune regulators--a new look

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Cytokine-modulated regulation of helper T cell populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

The role of type I interferon production by dendritic cells in host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Natural adjuvants: endogenous activators of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Toll-like receptors and Type I interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

The perfect mix: recent progress in adjuvant research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Defining the antigen-specific T-cell response to vaccination and poly(I:C)/TLR3 signaling: evidence of enhanced primary and memory CD8 T-cell responses and antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Immunostimulatory combinations: designing the next generation of vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

IRF3 mediates a TLR3/TLR4-specific antiviral gene program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

The interferon in TLR signaling: more than just antiviral

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Super-activated interferon-regulatory factors can enhance plasmid immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Regulation of DNA-raised immune responses by cotransfected interferon regulatory factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Gene therapy of cancer with interferon: lessons from tumor models and perspectives for clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Adjuvant activity of interferon alpha: mechanism(s) of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Administration of IFN-alpha enhances the efficacy of a granulocyte macrophage colony stimulating factor-secreting tumor cell vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Evaluation of the effects of human leukocyte IFN-α on the immune response to the HBV vaccine in healthy unvaccinated individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Anatomical basis of tolerance and immunity to intestinal antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Mucosal delivery of vaccine antigens and its advantages in pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Effect of oromucosal administration of IFN-alpha on allergic sensitization and the hypersensitive inflammatory response in animals sensitized to ragweed pollen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

The antitumor effects of interferon: a personal history

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

Dendritic cells and interferon-mediated autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

21 January 2018

DC-based cancer vaccines

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.373

21 January 2018

Identifiers

DOI

10.1586/14760584.7.3.373

1 reference

18 August 2017

1 reference